HomeXRTX • NASDAQ
add
XORTX Therapeutics Inc
Previous close
$2.43
Day range
$2.31 - $2.54
Year range
$1.98 - $7.52
Market cap
6.70M CAD
Avg Volume
15.00K
P/E ratio
-
Dividend yield
-
Primary exchange
CVE
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 675.11K | -72.40% |
Net income | 2.70M | 204.65% |
Net profit margin | — | — |
Earnings per share | -0.47 | 92.85% |
EBITDA | -667.12K | 72.67% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 3.45M | -66.96% |
Total assets | 5.47M | -55.81% |
Total liabilities | 825.94K | -84.64% |
Total equity | 4.64M | — |
Shares outstanding | 2.90M | — |
Price to book | 1.05 | — |
Return on assets | -27.88% | — |
Return on capital | -31.35% | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | 2.70M | 204.65% |
Cash from operations | -1.30M | 64.08% |
Cash from investing | -9.80K | 41.75% |
Cash from financing | -312.25K | -106.03% |
Net change in cash | -1.62M | -203.80% |
Free cash flow | -1.08M | 13.08% |
About
Founded
2011
Headquarters
Website
Employees
3